Cargando…

New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety

New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tănase, Constantin I., Drăghici, Constantin, Hanganu, Anamaria, Pintilie, Lucia, Maganu, Maria, Volobueva, Alexandrina, Sinegubova, Ekaterina, Zarubaev, Vladimir V., Neyts, Johan, Jochmans, Dirk, Slita, Alexander V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651170/
https://www.ncbi.nlm.nih.gov/pubmed/31277334
http://dx.doi.org/10.3390/molecules24132446
_version_ 1783438283482595328
author Tănase, Constantin I.
Drăghici, Constantin
Hanganu, Anamaria
Pintilie, Lucia
Maganu, Maria
Volobueva, Alexandrina
Sinegubova, Ekaterina
Zarubaev, Vladimir V.
Neyts, Johan
Jochmans, Dirk
Slita, Alexander V.
author_facet Tănase, Constantin I.
Drăghici, Constantin
Hanganu, Anamaria
Pintilie, Lucia
Maganu, Maria
Volobueva, Alexandrina
Sinegubova, Ekaterina
Zarubaev, Vladimir V.
Neyts, Johan
Jochmans, Dirk
Slita, Alexander V.
author_sort Tănase, Constantin I.
collection PubMed
description New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selective Mitsunobu reaction on the primary hydroxymethyl group in the presence of 5-endo-hydroxyl group. Adenine and 6-substituted adenine homonucleosides were obtained by the substitution of the 6-chlorine atom of the key intermediate 5 with ammonia and selected amines, and 6-methoxy- and 6-ethoxy substituted purine homonucleosides by reaction with the corresponding alkoxides. No derivatives appeared active against entero, yellow fever, chikungunya, and adeno type 1viruses. Two compounds (6j and 6d) had lower IC(50) (15 ± 2 and 21 ± 4 µM) and compound 6f had an identical value of IC(50) (28 ± 4 µM) to that of acyclovir, suggesting that the bicyclo[2.2.1]heptane skeleton could be further studied to find a candidate for sugar moiety of the nucleosides.
format Online
Article
Text
id pubmed-6651170
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66511702019-08-07 New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety Tănase, Constantin I. Drăghici, Constantin Hanganu, Anamaria Pintilie, Lucia Maganu, Maria Volobueva, Alexandrina Sinegubova, Ekaterina Zarubaev, Vladimir V. Neyts, Johan Jochmans, Dirk Slita, Alexander V. Molecules Article New 1′-homocarbanucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane skeleton as sugar moiety were synthesized. The pyrimidine analogs with uracil, 5-fluorouracil, thymine and cytosine and key intermediate with 6-chloropurine (5) as nucleobases were synthesized by a selective Mitsunobu reaction on the primary hydroxymethyl group in the presence of 5-endo-hydroxyl group. Adenine and 6-substituted adenine homonucleosides were obtained by the substitution of the 6-chlorine atom of the key intermediate 5 with ammonia and selected amines, and 6-methoxy- and 6-ethoxy substituted purine homonucleosides by reaction with the corresponding alkoxides. No derivatives appeared active against entero, yellow fever, chikungunya, and adeno type 1viruses. Two compounds (6j and 6d) had lower IC(50) (15 ± 2 and 21 ± 4 µM) and compound 6f had an identical value of IC(50) (28 ± 4 µM) to that of acyclovir, suggesting that the bicyclo[2.2.1]heptane skeleton could be further studied to find a candidate for sugar moiety of the nucleosides. MDPI 2019-07-03 /pmc/articles/PMC6651170/ /pubmed/31277334 http://dx.doi.org/10.3390/molecules24132446 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tănase, Constantin I.
Drăghici, Constantin
Hanganu, Anamaria
Pintilie, Lucia
Maganu, Maria
Volobueva, Alexandrina
Sinegubova, Ekaterina
Zarubaev, Vladimir V.
Neyts, Johan
Jochmans, Dirk
Slita, Alexander V.
New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title_full New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title_fullStr New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title_full_unstemmed New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title_short New HSV-1 Anti-Viral 1′-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety
title_sort new hsv-1 anti-viral 1′-homocarbocyclic nucleoside analogs with an optically active substituted bicyclo[2.2.1]heptane fragment as a glycoside moiety
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651170/
https://www.ncbi.nlm.nih.gov/pubmed/31277334
http://dx.doi.org/10.3390/molecules24132446
work_keys_str_mv AT tanaseconstantini newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT draghiciconstantin newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT hanganuanamaria newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT pintilielucia newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT maganumaria newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT volobuevaalexandrina newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT sinegubovaekaterina newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT zarubaevvladimirv newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT neytsjohan newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT jochmansdirk newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety
AT slitaalexanderv newhsv1antiviral1homocarbocyclicnucleosideanalogswithanopticallyactivesubstitutedbicyclo221heptanefragmentasaglycosidemoiety